Patent ID: 9498487
Filing Date: 2016-11-22
CPC Classification: A61K,A61P

Claim Text:
1. A topical administration composition comprising: (A) a cromolyn component selected from the group consisting of cromolyn and pharmaceutically acceptable salts thereof; (B) a delivery agent selected from the group consisting of N-(8-[2-hydroxybenzoyl]-amino)caprylic acid, 8-(2-hydroxybenzoylamino)-octanoic acid 2-{2-[2-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)ethoxy]ethyoxy}ethyl ester, and pharmaceutically acceptable salts thereof; (C) a semi-aqueous vehicle which is unconjugated PEG/water; and (D) (a) an excipient, wherein the topical administration composition provides a higher epidermal layer concentration of the cromolyn component over 8 hrs or 48 hrs after a single administration than a similar topical composition without the delivery agent compound.